Trading Statement

Omega Diagnostics Group PLC 10 April 2008 Omega Diagnostics Group PLC ('Omega' or 'the Group) Trading Update Omega, the AIM listed medical diagnostics company, announces that trading for the year ended 31st March 2008 was in line with market expectations with turnover showing an increase for the year of circa 70% over the previous year (year ended 31st March 2007: £2.03m). The increase in turnover follows the acquisition of Genesis Diagnostics Ltd and Cambridge Nutritional Sciences Ltd in September 2007 which contributed around 68% of the growth, and organic growth of around 2%. The directors are confident for the prospects of the Group for the new financial year and the Group will announce its results for the year ended 31st March 2008 during July 2008. Contacts: Omega Diagnostics Group PLC Landsbanki Securities Parkgreen Communications (UK) Limited Andrew Shepherd, Chief Executive Thilo Hoffmann Ben Knowles Kieron Harbinson, Finance Director Simon Brown Tel: 01259 763030 020 7426 9000 Tel: 020 7479 7933 www.omegadiagnostics.com Mob: 07900 346 978 ben.knowles@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
UK 100